THE IMPACT OF THE COVID-19 PANDEMIC ON INDIVIDUALS WITH DOWN SYNDROME: A CROATIAN SURVEY
Barišić A, Ergović Ravančić M, Majstorović D, Vraneković J
*Corresponding Author: Assoc. Prof. Jadranka Vraneković, Faculty of Medicine, University of Rijeka,
Department of Medical Biology and Genetics, B. Branchetta 20, 51000 Rijeka, Croatia;
tel: +385 (0)51 651 131, fax: +385 (0)51 678 896. Email: jadranka.vranekovic@medri.uniri.hr
page: 51
|
|
REFERENCES
1. Callea M, Cammarata-Scalisi F, Galeotti A, Villani
A, and Valentini D. COVID-19 and Down syndrome.
Acta Paediatr. 2020;109(9): 1901-1902.
2. Kazemi M, Salehi M, and Kheirollahi M. Down
Syndrome: Current Status, Challenges and Future
Perspectives. Int J Mol Cell Med. 2016;5(3): 125-133.
3. Antonarakis SE, Skotko BG, Rafii MS, Strydom A,
Pape SE, Bianchi DW, et al. Down syndrome. Nat
Rev Dis Primers. 2020;6(1): 9.
4. De Toma I, and Dierssen M. Network analysis of
Down syndrome and SARS-CoV-2 identifies risk
and protective factors for COVID-19. Sci Rep.
2021;11(1): 1930.
5. Illouz T, Biragyn A, Frenkel-Morgenstern M, Weiss-
berg O, Gorohovski A, Merzon E, et al. Specific Sus-
ceptibility to COVID-19 in Adults with Down Syn-
drome. Neuromolecular Med. 2021;23(4): 561-571.
6. Kantar A, Mazza A, Bonanomi E, Odoni M, Seminara
M, Verde ID, et al. COVID-19 and children with
Down syndrome: is there any real reason to worry?
Two case reports with severe course. BMC Pediatr.
2020;20(1): 561.
7. Emes D, Hüls A, Baumer N, Dierssen M, Puri S,
Russell L, et al. COVID-19 in Children with Down
Syndrome: Data from the Trisomy 21 Research So-
ciety Survey. Journal of Clinical Medicine. 2021;
10(21): 5125.
8. Embregts P, Heerkens L, Frielink N, Giesbers S, Vro-
mans L, and Jahoda A. Experiences of mothers caring for a child with an intellectual disability during the
COVID-19 pandemic in the Netherlands. J Intellect
Disabil Res. 2021;65(8): 760-771.
9. Amatori S, Sisti D, Perroni F, Brandi G, Rocchi MBL,
and Gobbi E. Physical activity, sedentary behaviour
and screen time among youths with Down syndrome
during the COVID-19 pandemic. J Intellect Disabil
Res. 2022;66(12): 903-912.
10. Shetty J, Shetty A, Mundkur SC, Dinesh TK, and
Pundir P. Economic burden on caregivers or parents
with Down syndrome children-a systematic review
protocol. Syst Rev. 2023;12(1): 3.
11. Sideropoulos V, Kye H, Dukes D, Samson AC,
Palikara O, and Van Herwegen J. Anxiety and Wor-
ries of Individuals with Down Syndrome During the
COVID-19 Pandemic: A Comparative Study in the
UK. J Autism Dev Disord. 2023;53(5): 2021-2036.
12. Rubenstein E, Kyprianou N, Kumar PS, Kriova AM,
Sokoloff A, Hillerstrom H, et al. Healthcare and Be-
havior Changes for Adults With Down Syndrome
1-Year Into COVID-19. Am J Intellect Dev Disabil.
2023;128(4): 273-281.
13. Meguid NA, Nashaat NH, Abdallah HR, Hemimi
M, Elnahry A, El-Hariri HM, et al. Influence of CO-
VID-19 pandemic lockdown on a sample of Egyptian
children with Down syndrome. Egypt J Med Hum
Genet. 2022;23(1): 68.
14. Santoro SL, Baker S, Blake JM, Cabrera MJ, Caugh-
man K, Chung J, et al. Views on the impact of the
COVID-19 pandemic on health in people with Down
syndrome from diverse backgrounds. Am J Med Gen-
et A. 2023;191(8): 2045-2056.
15. Fujino H, and Itai M. Disinfection behavior for CO-
VID-19 in individuals with Down syndrome and
caregivers’ distress in Japan: a cross-sectional ret-
rospective study. J Dev Phys Disabil. 2023;35(1):
81-96.
16. Pagnamenta E, Hodgkinson P, Davidson R, and Joffe
VL. The impact of COVID-19 (Coronavirus) on chil-
dren and young people with Down syndrome in the
United Kingdom. Front Psychol. 2023;14: 1175636.
17. Hartley SL, Fleming V, Piro-Gambetti B, Cohen A,
Ances BM, Yassa MA, et al. Impact of the COVID-19
pandemic on daily life, mood, and behavior of adults
with Down syndrome. Disabil Health J. 2022;15(3):
101278.
18. Hüls A, Feany PT, Zisman SI, Costa ACS, Diers-
sen M, Balogh R, et al. COVID-19 Vaccination of
Individuals with Down Syndrome—Data from the
Trisomy 21 Research Society Survey on Safety, Ef-
ficacy, and Factors Associated with the Decision to
Be Vaccinated. Vaccines. 2022; 10(4): 530.
19. Viner RM, Mytton OT, Bonell C, Melendez-Torres
GJ, Ward J, Hudson L, et al. Susceptibility to SARS-
CoV-2 Infection Among Children and Adolescents
Compared With Adults: A Systematic Review and
Meta-analysis. JAMA Pediatr. 2021;175(2): 143-156.
20. Turk MA, Landes SD, Formica MK, and Goss KD.
Intellectual and developmental disability and COV-
ID-19 case-fatality trends: TriNetX analysis. Disabil
Health J. 2020;13(3): 100942.
21. Pierce CA, Preston-Hurlburt P, Dai Y, Aschner CB,
Cheshenko N, Galen B, et al. Immune responses
to SARS-CoV-2 infection in hospitalized pediatric
and adult patients. Sci Transl Med. 2020;12(564):
eabd5487.
22. Yoshida M, Worlock KB, Huang N, Lindeboom RGH,
Butler CR, Kumasaka N, et al. Local and systemic
responses to SARS-CoV-2 infection in children and
adults. Nature. 2022;602(7896): 321-327.
23. Hatch-Stein JA, Zemel BS, Prasad D, Kalkwarf HJ,
Pipan M, Magge SN, et al. Body Composition and
BMI Growth Charts in Children With Down Syn-
drome. Pediatrics. 2016;138(4): e20160541.
24. Newman AM, Jhaveri R, Patel AB, Tan TQ, Toia JM,
and Arshad M. Trisomy 21 and Coronavirus Disease
2019 in Pediatric Patients. J Pediatr. 2021228: 294-296.
25. Pinku H, Hüls A, Feany PT, Baumer N, Dierssen M,
Bargagna S et al. Differences in clinical presenta-
tion, severity, and treatment of COVID-19 among
individuals with Down syndrome from India and
high-income countries: Data from the Trisomy 21
Research Society survey. J Glob Health. 2022;12:
05035
26. Santoro M, Coi A, Spadoni I, Bianchi F, and Pierini
A. Sex differences for major congenital heart defects
in Down Syndrome: A population based study. Eur J
Med Genet. 2018;61(9): 546-550.
27. Pfitzer C, Helm PC, Rosenthal LM, Berger F, Bauer
UMM, and Schmitt KR. Dynamics in prevalence of
Down syndrome in children with congenital heart
disease. Eur J Pediatr. 2018;177(1): 107-115.
28. Krishnan US, Krishnan SS, Jain S, Chavolla-Calderon
MB, Lewis M, Chung WK, et al. SARS-CoV-2 In-
fection in Patients with Down Syndrome, Congeni-
tal Heart Disease, and Pulmonary Hypertension: Is
Down Syndrome a Risk Factor? J Pediatr. 2020;225:
246-248.
29. Hamulka J, Jeruszka-Bielak M, Górnicka M, Drywień
ME, and Zielinska-Pukos MA. Dietary Supplements during COVID-19 Outbreak. Results of Google
Trends Analysis Supported by PLifeCOVID-19 On-
line Studies. Nutrients. 2020;13(1): 54.
30. Ani C, Grantham-McGregor S, and Muller D. Nutri-
tional supplementation in Down syndrome: theoreti-
cal considerations and current status. Dev Med Child
Neurol. 2000;42(3): 207-13.
31. Docherty AB, Harrison EM, Green CA, Hardwick
HE, Pius R, Norman L, et al. Features of 20 133 UK
patients in hospital with covid-19 using the ISARIC
WHO Clinical Characterisation Protocol: prospective
observational cohort study. BMJ. 2020;369: m1985.
32. Latos-Bieleńska A, Marcus E, Jamry-Dziurla A,
Rankin J, Barisic I, Cavero-Carbonell C, et al. 2022,
‘COVID-19 and children with congenital anomalies:
a European survey of parents’ experiences of health-
care services, BMJ Open. 2022. 12(7): e061428.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
